Report cover image

Allergic Rhinitis Treatment Market, By Treatment Type (Immunotherapy (SCIT, SLITD, SLITT), Anti-histamines, Decongestants, Leukotriene Receptor Antagonists, Corticosteroids), By Route of Administration (Oral, Nasal, Intraocular, Intravenous), By Distribut

Publisher Coherent Market Insights
Published May 20, 2022
Length 181 Pages
SKU # CMI17212494

Description

Allergic Rhinitis Treatment Market, By Treatment Type (Immunotherapy (SCIT, SLITD, SLITT), Anti-histamines, Decongestants, Leukotriene Receptor Antagonists, Corticosteroids), By Route of Administration (Oral, Nasal, Intraocular, Intravenous), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E-commerce), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Allergic rhinitis or hay fever is an IgE-mediated disorder caused by allergens such as mold or tress, animal, dander, house dust mites, weed pollens, and grass. It can occur in two different forms namely, seasonal and perennial, which in turn causes mild or moderate to severe inflammation inside the nose. Some of the major symptoms of allergic rhinitis include nasal congestion, rhinorrhea, sneezing, nasal itching, and itchy eyes, or it can be associated with asthma as well. Allergic rhinitis and sinusitis are linked to each other, as allergic rhinitis blocks the nose, which in turn blocks the sinuses. In 2015, according to World Allergy Organization, over 400 million people suffered from allergic rhinitis worldwide. Moreover, in the U.S., 10-30% adults and around 40% children were affected by allergic rhinitis.
Restraints of the Global Allergic Rhinitis Treatment Market
Major factors hampering the growth of the allergic rhinitis treatment market during the forecast period constitutes of absence of disease curing treatment, and similarity of symptoms with other diseases.
Key features of the study:
This report provides in-depth analysis of the global allergic rhinitis treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global allergic rhinitis treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Merck & Co., Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline PLC, Sanofi S.A., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Alcon (Novartis AG), Unichem Laboratories, Mylan, ALK, Innovus Pharmaceuticals, Inc., and Glenmark Pharmaceuticals Ltd.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global allergic rhinitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Allergic Rhinitis Treatment Market, By Treatment Type:
Immunotherapy
SCIT
SLITD
SLITT
Anti-histamines
Decongestants
Leukotriene Receptor Antagonists
Corticosteroids
Global Allergic Rhinitis Treatment Market, By Route of Administration:
Oral
Nasal
Intraocular
Intravenous
Global Allergic Rhinitis Treatment Market, By Distribution Channel:
Retail Pharmacies
Hospital Pharmacies
E-commerce
Global Allergic Rhinitis Treatment Market, By Geography:
North America
By Treatment Type
Immunotherapy
SCIT
SLITD
SLITT
Anti-histamines
Decongestants
Leukotriene Receptor Antagonists
Corticosteroids
By Route of Administration
Oral
Nasal
Intraocular
Intravenous
By Distribution Channel
Retail Pharmacies
Hospital Pharmacies
E-commerce
By Country:
U.S.
Canada
Europe
By Treatment Type
Immunotherapy
SCIT
SLITD
SLITT
Anti-histamines
Decongestants
Leukotriene Receptor Antagonists
Corticosteroids
By Route of Administration
Oral
Nasal
Intraocular
Intravenous
By Distribution Channel
Retail Pharmacies
Hospital Pharmacies
E-commerce
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Treatment Type
Immunotherapy
SCIT
SLITD
SLITT
Anti-histamines
Decongestants
Leukotriene Receptor Antagonists
Corticosteroids
By Route of Administration
Oral
Nasal
Intraocular
Intravenous
By Distribution Channel
Retail Pharmacies
Hospital Pharmacies
E-commerce
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Treatment Type
Immunotherapy
SCIT
SLITD
SLITT
Anti-histamines
Decongestants
Leukotriene Receptor Antagonists
Corticosteroids
By Route of Administration
Oral
Nasal
Intraocular
Intravenous
By Distribution Channel
Retail Pharmacies
Hospital Pharmacies
E-commerce
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Treatment Type
Immunotherapy
SCIT
SLITD
SLITT
Anti-histamines
Decongestants
Leukotriene Receptor Antagonists
Corticosteroids
By Route of Administration
Oral
Nasal
Intraocular
Intravenous
By Distribution Channel
Retail Pharmacies
Hospital Pharmacies
E-commerce
By Country:
GCC
Israel
Rest of Middle East
Africa
By Treatment Type
Immunotherapy
SCIT
SLITD
SLITT
Anti-histamines
Decongestants
Leukotriene Receptor Antagonists
Corticosteroids
By Route of Administration
Oral
Nasal
Intraocular
Intravenous
By Distribution Channel
Retail Pharmacies
Hospital Pharmacies
E-commerce
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Merck & Co., Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Boehringer Ingelheim
AstraZeneca Plc
GlaxoSmithKline PLC
Sanofi S.A.
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.
Alcon (Novartis AG)
Unichem Laboratories
Mylan
Innovus Pharmaceuticals, Inc.
Glenmark Pharmaceuticals Ltd.
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

181 Pages
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Treatment Type
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Regulatory Scenario
PEST Analysis
COVID-19 Impact Analysis
4. Global Allergic Rhinitis Treatment Market, By Treatment Type, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Immunotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
SCIT
SLITD
SLITT
Anti-histamines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Decongestants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Leukotriene Receptor Antagonists
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Corticosteroids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
5. Global Allergic Rhinitis Treatment Market, By Route of Administration, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Nasal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Intraocular
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Intravenous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. Global Allergic Rhinitis Treatment Market, By Distribution Channel, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
E-Commerce
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. Global Allergic Rhinitis Treatment Market, By Regions, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Company Profiles
Merck & Co., Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Boehringer Ingelheim
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
AstraZeneca
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline PLC
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Sanofi S.A.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Johnson & Johnson
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Alcon (Novartis AG)
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Unichem Laboratories
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Mylan Laboratories
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Innovus Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Glenmark Pharmaceuticals Ltd
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 35 market data tables and 26 figures on “Allergic Rhinitis Treatment Market – Global forecast to 2028.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us